A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Short Stature Children Due to Chronic Kidney Disease Before Transplantation
NCT03535415 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 68
Last updated 2018-11-23
Summary
This study aims to evaluate the efficacy and safety of recombinant human growth hormone injection in short stature children due to chronic kidney disease before transplantation.
Conditions
- Dwarfism
Interventions
- DRUG
-
Recombinant Human Growth Hormone Injection (rhGH)
rhGH 0.05mg/kg/d by subcutaneous injection
Sponsors & Collaborators
-
Children's Hospital of Fudan University
collaborator OTHER -
Beijing Children's Hospital
collaborator OTHER -
Shanghai Children's Hospital
collaborator OTHER -
Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
collaborator UNKNOWN -
The Children's Hospital of Zhejiang University School of Medicine
collaborator OTHER -
Children's Hospital of The Capital Institute of Pediatrics
collaborator OTHER -
Peking University First Hospital
collaborator OTHER -
Fuzhou General Hospital
collaborator OTHER -
The First Affiliated Hospital of Zhengzhou University
collaborator OTHER -
Shengjing Hospital
collaborator OTHER -
Children's Hospital of Chongqing Medical University
collaborator OTHER -
Tongji medical college huazhong university of science & technology
collaborator UNKNOWN -
Changchun GeneScience Pharmaceutical Co., Ltd.
lead INDUSTRY
Principal Investigators
-
Hong Xu, PhD · Children's Hospital of Fudan University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 2 Years
- Max Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-06-25
- Primary Completion
- 2020-09-30
- Completion
- 2021-09-30
Countries
- China
Study Locations
More Related Trials
-
A Study of PEG-somatropin in the Treatment of Children With Idiopathic Short Stature
NCT03221088 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of PEG-somatropin Injection to Treat Children of Turner Syndrome
NCT03189160 ·Status: UNKNOWN ·Phase: PHASE2
-
Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children
NCT01604395 ·Status: RECRUITING
-
Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children (Clinical Trial I)
NCT02380235 ·Status: UNKNOWN ·Phase: PHASE4
-
A Clinical Trial to Compare Pharmacokinetics of Two Different PEG-rhGH Preparations
NCT06135155 ·Status: COMPLETED ·Phase: PHASE1
-
Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children
NCT02314676 ·Status: UNKNOWN ·Phase: PHASE4
-
Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin
NCT00488124 ·Status: COMPLETED ·Phase: PHASE2
-
The Dosage Exploration Study of PEG-rhGH for Treating Short Stature in Prepubertal and Pubertal Children
NCT06768411 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone Injection in Patients With Prader-Willi Syndrome
NCT03554031 ·Status: UNKNOWN ·Phase: PHASE3
-
A Trial of YPEG-rhGH in Children With Short Stature
NCT05838885 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Study of PEG-rhGH Injection for Short Children Born Small for Gestational Age: Efficacy, Safety, and Pharmacokinetics
NCT07260500 ·Status: RECRUITING ·Phase: PHASE2
-
Treatment of Children With Insufficient Secretion of Growth Hormone
NCT00271518 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of Recombinant Human Growth Hormone Injection（JINTOPIN AQ）for Short Children With Small for SGA
NCT03221933 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized Clinical Trial of Two Different Initial Growth Hormone Doses in Children
NCT06103513 ·Status: RECRUITING ·Phase: PHASE3
-
Efficiency and Safety Study of Pegylated Somatropin to Treat Growth Hormone Deficiency Children
NCT01342146 ·Status: COMPLETED ·Phase: PHASE2
-
A Non-inferiority Phase 2 Study to Evaluate the Safety and Efficacy of PEG-rhGH in the Treatment of AGHD
NCT03104010 ·Status: UNKNOWN ·Phase: PHASE2
-
The Efficacy and Safety of PEGylated GH for the Treatment of Short Stature in Chinese Children-GLOBE Reg
NCT06037473 ·Status: RECRUITING
-
A Study to Evaluate the Efficacy of Somatropin in Adults With Growth Hormone Deficiency Caused by Trauma and/or Head Injury
NCT00638053 ·Status: TERMINATED ·Phase: PHASE4
-
Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency
NCT02976675 ·Status: UNKNOWN ·Phase: PHASE4
-
The Efficacy and Safety of Inpegsomatropin Injection in Children With Idiopathic Short Stature
NCT06927310 ·Status: RECRUITING ·Phase: PHASE3
-
Crossover Study to Assess the Safety and Pharmacokinetic of Pegylated Somatropin(PEG Somatropin) in GHD Children
NCT01613573 ·Status: COMPLETED ·Phase: PHASE1
-
Long-term Efficacy and Safety Evaluation of Growth Hormone in Children in China(CGLS)
NCT06110910 ·Status: RECRUITING
-
A Clinical Trail to Compare Pharmacokinetics of Two PEG-rhGH Injections With Different Preparations
NCT06135168 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency
NCT02908958 ·Status: UNKNOWN ·Phase: PHASE4
-
Growth Hormone in a Patient With a Dominant-Negative GHR Mutation
NCT05382637 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2